Robeco Institutional Asset Management B.V. lifted its position in shares of Aetna Inc (NYSE:AET) by 3.1% in the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 499,062 shares of the company’s stock after acquiring an additional 15,101 shares during the quarter. Robeco Institutional Asset Management B.V. owned approximately 0.15% of Aetna worth $101,234,000 at the end of the most recent reporting period.
Other hedge funds have also recently added to or reduced their stakes in the company. Wolverine Asset Management LLC raised its position in shares of Aetna by 31.7% during the second quarter. Wolverine Asset Management LLC now owns 47,351 shares of the company’s stock worth $8,688,000 after acquiring an additional 11,408 shares during the last quarter. Havens Advisors LLC raised its position in shares of Aetna by 32.1% during the third quarter. Havens Advisors LLC now owns 50,200 shares of the company’s stock worth $10,183,000 after acquiring an additional 12,200 shares during the last quarter. Mainstay Capital Management LLC ADV raised its position in shares of Aetna by 1,696.3% during the second quarter. Mainstay Capital Management LLC ADV now owns 11,209 shares of the company’s stock worth $162,000 after acquiring an additional 10,585 shares during the last quarter. Tokio Marine Asset Management Co. Ltd. raised its position in shares of Aetna by 712.3% during the third quarter. Tokio Marine Asset Management Co. Ltd. now owns 10,584 shares of the company’s stock worth $2,147,000 after acquiring an additional 9,281 shares during the last quarter. Finally, Abrams Capital Management L.P. raised its position in shares of Aetna by 14.1% during the second quarter. Abrams Capital Management L.P. now owns 1,575,000 shares of the company’s stock worth $289,013,000 after acquiring an additional 195,000 shares during the last quarter. Institutional investors own 83.46% of the company’s stock.
Shares of Aetna stock opened at $209.36 on Friday. The company has a quick ratio of 0.79, a current ratio of 0.79 and a debt-to-equity ratio of 0.42. Aetna Inc has a 12 month low of $166.88 and a 12 month high of $210.12. The firm has a market cap of $68.37 billion, a P/E ratio of 21.23, a P/E/G ratio of 1.77 and a beta of 0.71.
Aetna (NYSE:AET) last announced its quarterly earnings data on Tuesday, October 30th. The company reported $2.96 EPS for the quarter, topping analysts’ consensus estimates of $2.83 by $0.13. Aetna had a return on equity of 20.78% and a net margin of 5.99%. The business had revenue of $15.48 billion during the quarter, compared to analysts’ expectations of $15.40 billion. During the same period in the previous year, the firm earned $2.45 earnings per share. The firm’s quarterly revenue was up 3.3% compared to the same quarter last year. As a group, equities research analysts anticipate that Aetna Inc will post 11.36 earnings per share for the current fiscal year.
The business also recently disclosed a quarterly dividend, which was paid on Thursday, November 1st. Investors of record on Wednesday, October 24th were paid a dividend of $0.50 per share. The ex-dividend date was Tuesday, October 23rd. This represents a $2.00 dividend on an annualized basis and a dividend yield of 0.96%. Aetna’s dividend payout ratio (DPR) is presently 20.28%.
A number of equities research analysts recently commented on AET shares. Cantor Fitzgerald cut Aetna from an “overweight” rating to a “neutral” rating and set a $202.00 price objective for the company. in a research note on Wednesday, August 22nd. Zacks Investment Research raised Aetna from a “sell” rating to a “hold” rating in a research note on Monday, August 6th. Piper Jaffray Companies cut Aetna from an “overweight” rating to a “neutral” rating and decreased their price objective for the stock from $212.00 to $206.00 in a research note on Tuesday, October 30th. Credit Suisse Group decreased their price objective on Aetna from $207.00 to $205.00 and set a “neutral” rating for the company in a research note on Wednesday, October 31st. Finally, Citigroup lifted their price objective on Aetna from $202.00 to $206.00 and gave the stock a “neutral” rating in a research note on Wednesday, October 31st. Eight research analysts have rated the stock with a hold rating and four have issued a buy rating to the company. The stock has a consensus rating of “Hold” and an average target price of $204.55.
ILLEGAL ACTIVITY WARNING: This news story was reported by American Banking News and is the property of of American Banking News. If you are accessing this news story on another publication, it was illegally copied and republished in violation of United States and international trademark and copyright laws. The legal version of this news story can be viewed at https://www.americanbankingnews.com/2018/11/10/aetna-inc-aet-shares-bought-by-robeco-institutional-asset-management-b-v.html.
Aetna Inc operates as a health care benefits company in the United States. It operates through three segments: Health Care, Group Insurance, and Large Case Pensions. The Health Care segment offers medical, pharmacy benefit management service, dental, behavioral health, and vision plans on an insured and employer-funded basis.
Read More: What is the Rule of 72?
Want to see what other hedge funds are holding AET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aetna Inc (NYSE:AET).
Receive News & Ratings for Aetna Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna and related companies with MarketBeat.com's FREE daily email newsletter.